These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 5-HT1A-mediated lower lip retraction: effects of 5-HT1A agonists and antagonists. Moore NA, Rees G, Sanger G, Perrett L. Pharmacol Biochem Behav; 1993 Sep; 46(1):141-3. PubMed ID: 8255903 [Abstract] [Full Text] [Related]
3. In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats. Koek W, Assié MB, Zernig G, France CP. Psychopharmacology (Berl); 2000 May; 149(4):377-87. PubMed ID: 10867965 [Abstract] [Full Text] [Related]
4. Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys. McMahon LR. Drug Alcohol Depend; 2016 Aug 01; 165():87-93. PubMed ID: 27289270 [Abstract] [Full Text] [Related]
5. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system. Egashira N, Matsuda T, Koushi E, Higashihara F, Mishima K, Chidori S, Hasebe N, Iwasaki K, Nishimura R, Oishi R, Fujiwara M. Eur J Pharmacol; 2008 Jul 28; 589(1-3):117-21. PubMed ID: 18565508 [Abstract] [Full Text] [Related]
6. Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. Paronis CA, Nikas SP, Shukla VG, Makriyannis A. Behav Pharmacol; 2012 Dec 28; 23(8):802-5. PubMed ID: 23075707 [Abstract] [Full Text] [Related]
7. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors. Espejo-Porras F, Fernández-Ruiz J, Pertwee RG, Mechoulam R, García C. Neuropharmacology; 2013 Dec 28; 75():155-63. PubMed ID: 23924692 [Abstract] [Full Text] [Related]
8. 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats. Braida D, Limonta V, Malabarba L, Zani A, Sala M. Eur J Pharmacol; 2007 Jan 26; 555(2-3):156-63. PubMed ID: 17116299 [Abstract] [Full Text] [Related]
9. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Kleven MS, Assié MB, Koek W. J Pharmacol Exp Ther; 1997 Aug 26; 282(2):747-59. PubMed ID: 9262338 [Abstract] [Full Text] [Related]
10. Cross state-dependent memory retrieval between cannabinoid CB1 and serotonergic 5-HT1A receptor agonists in the mouse dorsal hippocampus. Jafari-Sabet M, Amiri S, Aghamiri H, Fatahi N. Neurobiol Learn Mem; 2022 Jul 26; 192():107638. PubMed ID: 35595026 [Abstract] [Full Text] [Related]
11. Role of dorsal and median raphe nuclei in lower lip retraction in rats. Berendsen HH, Bourgondien FG, Broekkamp CL. Eur J Pharmacol; 1994 Oct 03; 263(3):315-8. PubMed ID: 7843270 [Abstract] [Full Text] [Related]
12. Antagonism of 8-OH-DPAT-induced behaviour in rats. Berendsen HH, Broekkamp CL, Van Delft AM. Eur J Pharmacol; 1990 Oct 02; 187(1):97-103. PubMed ID: 2148726 [Abstract] [Full Text] [Related]
13. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat. Uvnäs-Moberg K, Ahlenius S, Alster P, Hillegaart V. Neuroendocrinology; 1996 Mar 02; 63(3):269-74. PubMed ID: 8677015 [Abstract] [Full Text] [Related]
14. Food restriction and streptozotocin treatment decrease 5-HT1A and 5-HT2A receptor-mediated behavioral effects in rats. Li JX, France CP. Behav Pharmacol; 2008 Jul 02; 19(4):292-7. PubMed ID: 18622176 [Abstract] [Full Text] [Related]
15. Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201. AlKhelb D, Burke EL, Zvonok A, Iliopoulos-Tsoutsouvas C, Georgiadis MO, Jiang S, Ho TC, Nikas SP, Makriyannis A, Desai RI. Eur J Pharmacol; 2023 Dec 05; 960():176168. PubMed ID: 38059442 [Abstract] [Full Text] [Related]
16. Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy. Prinssen EP, Koek W, Colpaert FC, Kleven MS. Behav Pharmacol; 2000 Jun 05; 11(3-4):299-305. PubMed ID: 11103884 [Abstract] [Full Text] [Related]
17. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors. Clarke RW, Ogilvie J, Houghton AK. Br J Pharmacol; 1997 Oct 05; 122(4):631-8. PubMed ID: 9375958 [Abstract] [Full Text] [Related]
18. Selective activation of 5HT1A receptors induces lower lip retraction in the rat. Berendsen HH, Jenck F, Broekkamp CL. Pharmacol Biochem Behav; 1989 Aug 05; 33(4):821-7. PubMed ID: 2533357 [Abstract] [Full Text] [Related]
19. Eating high fat chow increases the sensitivity of rats to 8-OH-DPAT-induced lower lip retraction. Li JX, Ju S, Baladi MG, Koek W, France CP. Behav Pharmacol; 2011 Dec 05; 22(8):751-7. PubMed ID: 21979831 [Abstract] [Full Text] [Related]
20. AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice. Järbe TU, Tai S, LeMay BJ, Nikas SP, Shukla VG, Zvonok A, Makriyannis A. Psychopharmacology (Berl); 2012 Mar 05; 220(2):417-26. PubMed ID: 21989802 [Abstract] [Full Text] [Related] Page: [Next] [New Search]